The prevalence of an uncommon ailelic 'variant (S2) of the apoprotein AI-CIII-AIV gene cluster was determined in noninsulin-dependent diabetics with or without evidence ofcoronary heart disease and in controls. Frequencies of the S2 allele were
Introduction
Recombinant deoxyribonucleic acid (DNA) probes have been used to identify DNA variants of the apoprotein AI-CIII-AIV gene Non-insulin-dependent diabetics have roughly twice the incidence of coronary heart disease compared with age matched non-diabetic subjects.5 Though the prevalence of various environmental risk factors for atherogenesis in diabetes has been intensively studied,6 the role of inherited factors has been largely ignored. We therefore decided to study the distribution of the apoprotein CIII genotype in a group of carefully defined non-insulin-dependent diabetics with evidence of coronary heart disease to see whether similar genetic determinants occur in this important subgroup of patients with arterial disease. Recognising major genes concerned in the pathogenesis of atherosclerotic arterial disease would considerably expand our understanding of this process and, by identifying susceptible people at an early age, may allow the introduction of preventive measures.7
Patients and methods 
Results
After digestion with the restriction endonuclease Sst 1 three gene related fragments were visualised by hybridisation with an apoprotein Al probe (figure) 
Discussi'on
We have studied a variant of the apoprotein AI-CIII-AIV gene cluster which associates with coronary heart disease in non-insulindependent diabetics and provides evidence for a genetic component in the aetiology of this important long -term diabetic complication. At present it is not clear whethe'r polymorphisms at this gene cluster are aetiological for atherosclerosis. DNA variation at this locus mih_reips to coonr ateoceoi by altrn plasma lipi cocnrtos Possso of th S2 allle hoevr doe no apea to inluec cocnrain of cicltigsru pprti Al or appoti Gl. AtraIvl th obevdascainwt coonr her dies in n -inslndeedn dibtc may arise from linkage disequilibrium with other atherogenic loci on chromosome 1 1. Three further points emerge from our study. The results from the non-insulin-dependent diabetics with coronary heart disease who were normolipaemic at the time of study suggest that the observed increase in frequency of the S2 allele was independent of any association with diabetic hypertriglyceridaemia. No significant differences in the frequencies ofthe S2 allele were observed between normotriglyceridaemic and hypertriglyceridaemic diabetics with clinical evidence of vascular disease. Nevertheless, of all subjects with diabetes and coronary heart disease, 20 (43%) had fasting hypertriglyceridaemia at the time of study and six of these patients were heterozygous for the S2 allele. This supports previous data on the increased -frequency of the S2 allele in diabetic hypertriglyceridaemia.I" Finally, no significant difference in frequencies of alleles was found between normotriglyceridaemic diabetics without clinical evidence of vascular disease and the non-diabetic controls. Hence there appears to be no disease association between diabetes alone and this DNA variant of the apoprotein CIII gene.
Though our observations provide evidence for at least one common genetic determinant for coronary heart disease in both diabetics and non-diabetics, we cannot exclude the possibility of differences in the contribution of other loci to the predisposition to coronary heart disease in diabetes. (Accepted 2April 1987) 100 YEARS AGO Attention has been called by a contemporary to a system of fraud which has been practised in connection with the working of the new French law which enjoins that all packages containing butter substitutes shall be specially marked with words denoting the admixture, the term usually employed being graisse alimentaire. This law has led to the discovery that a large amount of the "guaranteed" French butter is either butterine or an admixture.
Manufacturers in France who are now compelled by French law to brand these goods do so, but large quantites are marked in addition "guaranteed pure butter," and when the goods arrive in this country the words graisse alimentaire are removed. One of the southern railway companies has, it is said, actually fixed a tariff for the commission of this fraud, and other companies allow it to be perpetrated by the owner while the goods are in transit. Such frauds should be summarily suppressed, and, if necessary, the law should be strengthened in order that the perpetrators may be severely punished. (British MedicalJtournal 1887;ii:369.)
